PTGX Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2022-04-13 | 2021 | Dinesh V. Patel, Ph.D. President and Chief Executive Officer | 600,000 | 0 | 589,250 | 429,000 | 7,118 | 5,544,733 |
| 2022-04-13 | 2020 | Dinesh V. Patel, Ph.D. President and Chief Executive Officer | 565,000 | 0 | 0 | 473,894 | 3,573 | 2,225,622 |
| 2022-04-13 | 2021 | David Y. Liu, Ph.D. Chief Research and Development Strategy Officer | 455,000 | 0 | 235,700 | 233,188 | 14,678 | 2,070,827 |
| 2022-04-13 | 2020 | David Y. Liu, Ph.D. Chief Research and Development Strategy Officer | 441,300 | 0 | 0 | 266,987 | 11,133 | 1,071,849 |
| 2022-04-13 | 2021 | Suneel Gupta, Ph.D Chief Development Officer | 455,000 | 0 | 282,840 | 236,600 | 7,118 | 2,375,110 |
| 2022-04-13 | 2020 | Suneel Gupta, Ph.D Chief Development Officer | 420,000 | 0 | 0 | 256,200 | 4,120 | 1,108,270 |
| 2021-04-14 | 2020 | Dinesh V. Patel, Ph.D. President and Chief Executive Officer | 565,000 | 0 | 0 | 473,894 | 3,573 | 2,225,622 |
| 2021-04-14 | 2019 | Dinesh V. Patel, Ph.D. President and Chief Executive Officer | 545,000 | 0 | 230,575 | 354,250 | 4,164 | 1,948,344 |
| 2021-04-14 | 2020 | David Y. Liu, Ph.D. Chief Scientific Officer and Head of Discovery and Pre-Clinical Development | 441,300 | 0 | 0 | 266,987 | 11,133 | 1,071,849 |
| 2021-04-14 | 2019 | David Y. Liu, Ph.D. Chief Scientific Officer and Head of Discovery and Pre-Clinical Development | 428,450 | 0 | 120,300 | 218,509 | 7,458 | 1,199,598 |
| 2021-04-14 | 2020 | Suneel Gupta, Ph.D. Chief Development Officer | 420,000 | 0 | 0 | 256,200 | 4,120 | 1,108,270 |
| 2021-04-14 | 2019 | Suneel Gupta, Ph.D. Chief Development Officer | 377,467 | 0 | 60,150 | 196,767 | 3,564 | 1,331,737 |
| 2020-04-16 | 2018 | Suneel Gupta, Ph.D. Chief Development Officer | 0 | 0 | 0 | 0 | 98,105 | 98,105 |
| 2020-04-16 | 2019 | Dinesh V. Patel, Ph.D. President and Chief | 545,000 | 0 | 230,575 | 354,250 | 4,164 | 1,948,344 |
| 2020-04-16 | 2018 | Dinesh V. Patel, Ph.D. President and Chief | 520,000 | 0 | 1,127,739 | 221,000 | 10,844 | 3,721,511 |
| 2020-04-16 | 2019 | David Y. Liu, Ph.D. Chief Scientific Officer and | 428,450 | 0 | 120,300 | 218,509 | 7,458 | 1,199,598 |
| 2020-04-16 | 2018 | David Y. Liu, Ph.D. Chief Scientific Officer and | 410,000 | 0 | 382,389 | 141,500 | 7,458 | 1,618,355 |
| 2020-04-16 | 2019 | Suneel Gupta, Ph.D. Chief Development Officer | 377,467 | 0 | 60,150 | 196,767 | 3,564 | 1,331,737 |
| 2019-04-26 | 2018 | Dinesh V. Patel, Ph.D. President and Chief | 520,000 | 0 | 1,127,739 | 221,000 | 10,844 | 3,721,511 |
| 2019-04-26 | 2017 | Dinesh V. Patel, Ph.D. President and Chief | 475,000 | 0 | 0 | 309,000 | 6,088 | 790,088 |
| 2019-04-26 | 2017 | Richard S. Shames, M.D. Chief Medical Officer | 357,000 | 0 | 0 | 179,000 | 3,279 | 539,279 |
| 2019-04-26 | 2018 | Richard S. Shames, M.D. Chief Medical Officer | 400,000 | 0 | 271,050 | 130,000 | 2,322 | 1,258,060 |
| 2019-04-26 | 2017 | David Y. Liu, Ph.D. Chief Scientific Officer and | 357,000 | 0 | 0 | 186,000 | 9,168 | 552,168 |
| 2019-04-26 | 2018 | David Y. Liu, Ph.D. Chief Scientific Officer and | 410,000 | 0 | 382,389 | 141,500 | 7,458 | 1,618,355 |
| 2018-04-18 | 2016 | Richard S. Shames, M.D. Chief Medical Officer | 326,000 | 0 | 0 | 96,578 | 420 | 1,332,531 |
| 2018-04-18 | 2017 | Dinesh V. Patel, Ph.D. President and Chief | 475,000 | 0 | 0 | 309,000 | 6,088 | 790,088 |
| 2018-04-18 | 2016 | Dinesh V. Patel, Ph.D. President and Chief | 400,000 | 0 | 0 | 160,000 | 0 | 4,990,240 |
| 2018-04-18 | 2017 | David Y. Liu, Ph.D. Chief Scientific Officer and | 357,000 | 0 | 0 | 186,000 | 9,168 | 552,168 |
| 2018-04-18 | 2016 | David Y. Liu, Ph.D. Chief Scientific Officer and | 310,000 | 0 | 0 | 93,000 | 0 | 1,325,707 |
| 2018-04-18 | 2017 | Richard S. Shames, M.D. Chief Medical Officer | 357,000 | 0 | 0 | 179,000 | 3,279 | 539,279 |
| 2017-04-24 | 2015 | Dinesh V. Patel, Ph.D. President and Chief Executive Officer | 386,250 | 0 | 0 | 128,428 | 0 | 602,408 |
| 2017-04-24 | 2016 | Dinesh V. Patel, Ph.D. President and Chief Executive Officer | 400,000 | 0 | 0 | 160,000 | 0 | 4,990,240 |
| 2017-04-24 | 2015 | Richard Shames, M.D. Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2017-04-24 | 2016 | Richard Shames, M.D. Chief Medical Officer | 326,000 | 0 | 0 | 96,578 | 420 | 1,332,531 |
| 2017-04-24 | 2015 | David Y. Liu, Ph.D. Chief Scientific Officer and Head of Research & Development | 275,891 | 0 | 0 | 65,524 | 0 | 371,004 |
| 2017-04-24 | 2016 | David Y. Liu, Ph.D. Chief Scientific Officer and Head of Research & Development | 310,000 | 0 | 0 | 93,000 | 0 | 1,325,707 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
